June 6, 2017
2:17-cv-02555
Class Action
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Drugmakers have unlawfully colluded to prevent competition for a generic numbing ointment as well as treatments for gallbladder stones, seizures and eczema, consequently inflating prices paid by direct purchasers, according to four separate antitrust suits filed Tuesday as part of multidistrict litigation in Pennsylvania federal court.
Already a subscriber? Click here to login